Hongtao Liu
University of Wisconsin, Madison · UW Carbone Cancer Center · The First Affiliated Hospital of USTC, University of Science and Technology of China
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hongtao Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:58 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07909733 · Maintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allo-SCTUniversity of Wisconsin, Madison · not yet recruiting · High-risk Myeloid Malignancy, Allogenic Stem Cell Transplantation, Acute Myeloid Leukemia (AML) · principal investigator
- N/ANCT07285668 · Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic MalignanciesUniversity of Wisconsin, Madison · recruiting · Hematologic Malignancies · principal investigator
- N/ANCT04562051 · Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- RecipientsWest China Hospital · unknown · Kidney Transplantation, HBV · principal investigator
- Ph1NCT02985554 · Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic MalignanciesUniversity of Chicago · terminated · Hematologic Malignancies · principal investigator
- Ph1NCT02573363 · Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid LeukemiaUniversity of Chicago · completed · Acute Myeloid Leukemia · principal investigator
- Ph1NCT02485535 · Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After TransplantUniversity of Chicago · completed · Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome · principal investigator
- Ph1NCT02333162 · Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantUniversity of Chicago · suspended · Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia · principal investigator
- Ph1NCT01842139 · Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete RemissionUniversity of Chicago · completed · Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) · principal investigator
- Ph2NCT01839916 · Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesUniversity of Chicago · completed · Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) · principal investigator
- N/ANCT00943800 · Combined Haploidentical-Cord Blood Transplantation for Adults and ChildrenUniversity of Chicago · completed · Leukemia, Myelodysplastic Syndrome, Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Immunology and CancerP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI THOMAS F GAJEWSKI · fiscal years 2010 to 2026
Most cited trial papers
Clinical-trial papers with this author name in chronic myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 10:58 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed